Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.990
-0.060 (-1.97%)
At close: Aug 1, 2025, 4:00 PM
3.030
+0.040 (1.34%)
After-hours: Aug 1, 2025, 7:12 PM EDT
Rocket Pharmaceuticals Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$14.79
Upside
+394.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +234.45% | Jul 25, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $9 → $4 | Strong Buy → Hold | Downgrades | $9 → $4 | +33.78% | Jul 25, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $12 | Strong Buy | Maintains | $17 → $12 | +301.34% | Jul 24, 2025 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jul 24, 2025 |
| UBS | UBS | Strong Buy Maintains $12 → $5 | Strong Buy | Maintains | $12 → $5 | +67.22% | Jun 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $34 → $11 | Strong Buy | Maintains | $34 → $11 | +267.89% | Jun 3, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $32 → $9 | Strong Buy | Maintains | $32 → $9 | +201.00% | May 28, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $30 → $8 | Buy | Maintains | $30 → $8 | +167.56% | May 28, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $51 → $19 | Buy | Maintains | $51 → $19 | +535.45% | May 28, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $37 → $8 | Buy → Hold | Downgrades | $37 → $8 | +167.56% | May 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $46 → $17 | Strong Buy | Maintains | $46 → $17 | +468.56% | May 28, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $29 → $2.5 | Strong Buy → Hold | Downgrades | $29 → $2.5 | -16.39% | May 28, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $34 → $32 | Strong Buy | Maintains | $34 → $32 | +970.23% | May 27, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades $42 | Strong Buy → Hold | Downgrades | $42 | +1,304.68% | May 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $20 → $30 | Buy | Maintains | $20 → $30 | +903.34% | May 16, 2025 |
| Wedbush | Wedbush | Buy Reiterates $32 | Buy | Reiterates | $32 | +970.23% | May 16, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.